rs3176447

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001429675.1(CDKN2C):​c.-1896T>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0777 in 152,354 control chromosomes in the GnomAD database, including 520 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.078 ( 520 hom., cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CDKN2C
NM_001429675.1 5_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.529

Publications

11 publications found
Variant links:
Genes affected
CDKN2C (HGNC:1789): (cyclin dependent kinase inhibitor 2C) The protein encoded by this gene is a member of the INK4 family of cyclin-dependent kinase inhibitors. This protein has been shown to interact with CDK4 or CDK6, and prevent the activation of the CDK kinases, thus function as a cell growth regulator that controls cell cycle G1 progression. Ectopic expression of this gene was shown to suppress the growth of human cells in a manner that appears to correlate with the presence of a wild-type RB1 function. Studies in the knockout mice suggested the roles of this gene in regulating spermatogenesis, as well as in suppressing tumorigenesis. Two alternatively spliced transcript variants of this gene, which encode an identical protein, have been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001429675.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.107 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001429675.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDKN2C
NM_001429675.1
c.-1896T>A
5_prime_UTR
Exon 2 of 4NP_001416604.1Q6ICV4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDKN2C
ENST00000262662.5
TSL:2
c.-1896T>A
5_prime_UTR
Exon 2 of 4ENSP00000262662.1P42773
CDKN2C
ENST00000855560.1
c.-1126-770T>A
intron
N/AENSP00000525619.1
ENSG00000290102
ENST00000702980.2
n.598A>T
non_coding_transcript_exon
Exon 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.0777
AC:
11822
AN:
152234
Hom.:
518
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0694
Gnomad AMI
AF:
0.0592
Gnomad AMR
AF:
0.0620
Gnomad ASJ
AF:
0.146
Gnomad EAS
AF:
0.115
Gnomad SAS
AF:
0.0604
Gnomad FIN
AF:
0.0453
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0867
Gnomad OTH
AF:
0.0759
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
16
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
12
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
8
Other (OTH)
AF:
0.00
AC:
0
AN:
4
GnomAD4 genome
AF:
0.0777
AC:
11834
AN:
152354
Hom.:
520
Cov.:
33
AF XY:
0.0756
AC XY:
5629
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.0693
AC:
2882
AN:
41576
American (AMR)
AF:
0.0619
AC:
947
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.146
AC:
508
AN:
3472
East Asian (EAS)
AF:
0.115
AC:
595
AN:
5186
South Asian (SAS)
AF:
0.0600
AC:
290
AN:
4830
European-Finnish (FIN)
AF:
0.0453
AC:
481
AN:
10628
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0867
AC:
5896
AN:
68030
Other (OTH)
AF:
0.0803
AC:
170
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
571
1142
1714
2285
2856
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0323
Hom.:
21
Bravo
AF:
0.0789
Asia WGS
AF:
0.112
AC:
389
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
2.5
DANN
Benign
0.64
PhyloP100
-0.53
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs3176447;
hg19: chr1-51433687;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.